ARCHIVES

Phase III Trial Finds Cabazitaxel Increases Survival Of Advanced Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 3 | March 26, 2010

Download PDF Visit The Full Archive

Related Articles

ONS Award Winners, Grantees, Announced At Annual Congress

July 27, 1990

NI Communications Effort, Saves By Congress, Now A Major National Cancer Program Resource

August 15, 1975

ODAC Recommends Fludarabine Approval for Refractory CLL

September 21, 1990

Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC

February 26, 2010

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

September 3, 1993

Advisors’ Report On Intramural Program To Recommend Restructuring

April 14, 1995